Dolphin Medical Services Ltd.
| BSE: 526504 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE796B01013 |
| BSE 00:00 | 06 May | 3.06 |
0.14 (4.79%) |
OPEN
3.06 |
HIGH
3.06 |
LOW
3.05 |
| NSE 05:30 | 01 Jan | Dolphin Medical Services Ltd |
| OPEN | 3.06 |
| PREVIOUS CLOSE | 2.92 |
| VOLUME | 133036 |
| 52-Week high | 3.06 |
| 52-Week low | 0.82 |
| P/E | |
| Mkt Cap.(Rs cr) | 5 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dolphin Medical Services Ltd. (DOLPHINMEDICAL) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 679.25 | -4.05 | -0.59 | 3211.14 |
| Dr Reddy's Labs | 5165.65 | 5.05 | 0.10 | 2937.70 |
| Cipla | 883.80 | -4.90 | -0.55 | 2318.17 |
| Aurobindo Pharma | 1008.50 | -9.60 | -0.94 | 1872.74 |
| Cadila Health. | 601.80 | 0.25 | 0.04 | 1412.90 |
| Divi's Lab. | 4062.55 | 27.30 | 0.68 | 1372.71 |
| Glenmark Pharma. | 569.95 | -3.45 | -0.60 | 1354.55 |
| Alkem Lab | 2861.60 | -38.50 | -1.33 | 1264.42 |
| Alembic Pharma | 940.80 | -15.20 | -1.59 | 969.40 |
| Torrent Pharma. | 2609.40 | -14.10 | -0.54 | 938.51 |
| Gland Pharma | 2632.85 | 23.90 | 0.92 | 772.86 |
| Lupin | 1197.05 | -3.45 | -0.29 | 727.55 |
| Ipca Labs. | 2097.05 | -12.70 | -0.60 | 652.46 |
| Abbott India | 15424.30 | 28.60 | 0.19 | 592.93 |
| Fortis Health. | 219.65 | -1.50 | -0.68 | 513.33 |
| Pfizer | 5324.15 | -120.80 | -2.22 | 509.13 |
| Sanofi India | 7696.90 | 5.45 | 0.07 | 477.60 |
| Natco Pharma | 944.25 | 11.95 | 1.28 | 474.50 |
| Apollo Hospitals | 3344.65 | 8.25 | 0.25 | 470.30 |
| Granules India | 351.50 | -0.95 | -0.27 | 444.07 |
Quick Links for Dolphin Medical Services:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
